State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, Ages 50+

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 64.2 with a 95% confidence interval from 64.0 to 64.4 and 72,697 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 59.1

Mississippi⁶

• Rate : The incidence rate is 86.6 with a 95% confidence interval from 84.0 to 89.2 and 902 average annual cases over 2017-2021.
• CI*Rank ⋔ : 1 (1, 1)
• Percent of Cases with Late Stage : 61.2

West Virginia⁶

• Rate : The incidence rate is 78.6 with a 95% confidence interval from 75.7 to 81.5 and 585 average annual cases over 2017-2021.
• CI*Rank ⋔ : 2 (2, 7)
• Percent of Cases with Late Stage : 59.4

Kentucky³

• Rate : The incidence rate is 77.3 with a 95% confidence interval from 75.3 to 79.2 and 1,243 average annual cases over 2017-2021.
• CI*Rank ⋔ : 3 (2, 7)
• Percent of Cases with Late Stage : 56.4

Louisiana³

• Rate : The incidence rate is 76.4 with a 95% confidence interval from 74.4 to 78.4 and 1,222 average annual cases over 2017-2021.
• CI*Rank ⋔ : 4 (2, 8)
• Percent of Cases with Late Stage : 57.5

Alaska⁶

• Rate : The incidence rate is 75.7 with a 95% confidence interval from 70.2 to 81.5 and 157 average annual cases over 2017-2021.
• CI*Rank ⋔ : 5 (2, 17)
• Percent of Cases with Late Stage : 60.7

Arkansas⁶

• Rate : The incidence rate is 74.3 with a 95% confidence interval from 72.0 to 76.7 and 809 average annual cases over 2017-2021.
• CI*Rank ⋔ : 6 (3, 11)
• Percent of Cases with Late Stage : 60.0

South Dakota⁶

• Rate : The incidence rate is 74.3 with a 95% confidence interval from 70.0 to 78.8 and 235 average annual cases over 2017-2021.
• CI*Rank ⋔ : 7 (2, 16)
• Percent of Cases with Late Stage : 62.8

Missouri⁶

• Rate : The incidence rate is 71.9 with a 95% confidence interval from 70.3 to 73.5 and 1,614 average annual cases over 2017-2021.
• CI*Rank ⋔ : 8 (5, 13)
• Percent of Cases with Late Stage : 61.9

Illinois³

• Rate : The incidence rate is 71.6 with a 95% confidence interval from 70.5 to 72.8 and 3,190 average annual cases over 2017-2021.
• CI*Rank ⋔ : 9 (6, 13)
• Percent of Cases with Late Stage : 60.8

North Dakota⁶

• Rate : The incidence rate is 70.9 with a 95% confidence interval from 66.3 to 75.8 and 182 average annual cases over 2017-2021.
• CI*Rank ⋔ : 10 (3, 24)
• Percent of Cases with Late Stage : 60.9

Ohio⁶

• Rate : The incidence rate is 70.7 with a 95% confidence interval from 69.6 to 71.8 and 3,079 average annual cases over 2017-2021.
• CI*Rank ⋔ : 11 (7, 14)
• Percent of Cases with Late Stage : 60.6

Tennessee⁶

• Rate : The incidence rate is 70.1 with a 95% confidence interval from 68.6 to 71.7 and 1,709 average annual cases over 2017-2021.
• CI*Rank ⋔ : 12 (7, 17)
• Percent of Cases with Late Stage : 60.8

Kansas⁶

• Rate : The incidence rate is 69.7 with a 95% confidence interval from 67.3 to 72.0 and 698 average annual cases over 2017-2021.
• CI*Rank ⋔ : 13 (7, 21)
• Percent of Cases with Late Stage : 59.7

Pennsylvania⁶

• Rate : The incidence rate is 68.9 with a 95% confidence interval from 67.9 to 69.9 and 3,506 average annual cases over 2017-2021.
• CI*Rank ⋔ : 14 (10, 19)
• Percent of Cases with Late Stage : 61.7

Texas³

• Rate : The incidence rate is 68.6 with a 95% confidence interval from 67.8 to 69.4 and 5,748 average annual cases over 2017-2021.
• CI*Rank ⋔ : 15 (11, 19)
• Percent of Cases with Late Stage : 60.0

Georgia³

• Rate : The incidence rate is 67.7 with a 95% confidence interval from 66.4 to 68.9 and 2,295 average annual cases over 2017-2021.
• CI*Rank ⋔ : 16 (12, 22)
• Percent of Cases with Late Stage : 57.4

Oklahoma⁶

• Rate : The incidence rate is 67.3 with a 95% confidence interval from 65.3 to 69.3 and 902 average annual cases over 2017-2021.
• CI*Rank ⋔ : 17 (11, 24)
• Percent of Cases with Late Stage : 56.0

Nebraska⁶

• Rate : The incidence rate is 66.7 with a 95% confidence interval from 63.9 to 69.6 and 441 average annual cases over 2017-2021.
• CI*Rank ⋔ : 18 (10, 29)
• Percent of Cases with Late Stage : 56.9

Montana⁶

• Rate : The incidence rate is 66.3 with a 95% confidence interval from 62.7 to 70.0 and 274 average annual cases over 2017-2021.
• CI*Rank ⋔ : 19 (9, 31)
• Percent of Cases with Late Stage : 60.3

Iowa³

• Rate : The incidence rate is 66.3 with a 95% confidence interval from 64.2 to 68.4 and 772 average annual cases over 2017-2021.
• CI*Rank ⋔ : 20 (12, 27)
• Percent of Cases with Late Stage : 55.8

New Jersey³

• Rate : The incidence rate is 65.8 with a 95% confidence interval from 64.6 to 67.1 and 2,201 average annual cases over 2017-2021.
• CI*Rank ⋔ : 21 (16, 25)
• Percent of Cases with Late Stage : 57.3

Idaho³

• Rate : The incidence rate is 65.0 with a 95% confidence interval from 62.1 to 68.0 and 393 average annual cases over 2017-2021.
• CI*Rank ⋔ : 22 (13, 32)
• Percent of Cases with Late Stage : 61.7

Wyoming⁶

• Rate : The incidence rate is 64.5 with a 95% confidence interval from 59.6 to 69.8 and 131 average annual cases over 2017-2021.
• CI*Rank ⋔ : 23 (8, 41)
• Percent of Cases with Late Stage : 60.2

Alabama⁶

• Rate : The incidence rate is 64.5 with a 95% confidence interval from 62.8 to 66.1 and 1,186 average annual cases over 2017-2021.
• CI*Rank ⋔ : 24 (18, 30)
• Percent of Cases with Late Stage : 54.1

North Carolina⁶

• Rate : The incidence rate is 64.1 with a 95% confidence interval from 62.9 to 65.3 and 2,346 average annual cases over 2017-2021.
• CI*Rank ⋔ : 25 (20, 30)
• Percent of Cases with Late Stage : 61.4

Florida⁶

• Rate : The incidence rate is 63.2 with a 95% confidence interval from 62.4 to 63.9 and 5,656 average annual cases over 2017-2021.
• CI*Rank ⋔ : 26 (22, 31)
• Percent of Cases with Late Stage : 59.0

Hawaii³

• Rate : The incidence rate is 63.1 with a 95% confidence interval from 60.1 to 66.2 and 352 average annual cases over 2017-2021.
• CI*Rank ⋔ : 27 (17, 38)
• Percent of Cases with Late Stage : 57.0

South Carolina⁶

• Rate : The incidence rate is 62.8 with a 95% confidence interval from 61.2 to 64.4 and 1,200 average annual cases over 2017-2021.
• CI*Rank ⋔ : 28 (21, 34)
• Percent of Cases with Late Stage : 60.4

Michigan⁶

• Rate : The incidence rate is 62.5 with a 95% confidence interval from 61.4 to 63.7 and 2,339 average annual cases over 2017-2021.
• CI*Rank ⋔ : 29 (23, 33)
• Percent of Cases with Late Stage : 59.7

Wisconsin⁶

• Rate : The incidence rate is 62.3 with a 95% confidence interval from 60.8 to 63.9 and 1,349 average annual cases over 2017-2021.
• CI*Rank ⋔ : 30 (22, 35)
• Percent of Cases with Late Stage : 60.9

Maryland⁶

• Rate : The incidence rate is 61.6 with a 95% confidence interval from 60.1 to 63.1 and 1,319 average annual cases over 2017-2021.
• CI*Rank ⋔ : 31 (24, 36)
• Percent of Cases with Late Stage : 59.3

Washington⁵

• Rate : The incidence rate is 60.2 with a 95% confidence interval from 58.9 to 61.6 and 1,528 average annual cases over 2017-2021.
• CI*Rank ⋔ : 32 (29, 40)
• Percent of Cases with Late Stage : 60.5

Minnesota⁶

• Rate : The incidence rate is 60.1 with a 95% confidence interval from 58.6 to 61.7 and 1,189 average annual cases over 2017-2021.
• CI*Rank ⋔ : 33 (28, 41)
• Percent of Cases with Late Stage : 56.5

New York³

• Rate : The incidence rate is 60.0 with a 95% confidence interval from 59.2 to 60.8 and 4,373 average annual cases over 2017-2021.
• CI*Rank ⋔ : 34 (30, 39)
• Percent of Cases with Late Stage : 56.5

New Hampshire⁶

• Rate : The incidence rate is 59.8 with a 95% confidence interval from 56.9 to 62.9 and 327 average annual cases over 2017-2021.
• CI*Rank ⋔ : 35 (23, 45)
• Percent of Cases with Late Stage : 60.8

Virginia⁶

• Rate : The incidence rate is 58.8 with a 95% confidence interval from 57.6 to 60.1 and 1,733 average annual cases over 2017-2021.
• CI*Rank ⋔ : 36 (32, 42)
• Percent of Cases with Late Stage : 58.5

Maine⁶

• Rate : The incidence rate is 58.6 with a 95% confidence interval from 55.8 to 61.5 and 346 average annual cases over 2017-2021.
• CI*Rank ⋔ : 37 (28, 47)
• Percent of Cases with Late Stage : 57.8

Oregon⁶

• Rate : The incidence rate is 58.5 with a 95% confidence interval from 56.7 to 60.3 and 893 average annual cases over 2017-2021.
• CI*Rank ⋔ : 38 (31, 44)
• Percent of Cases with Late Stage : 60.2

Delaware⁶

• Rate : The incidence rate is 58.4 with a 95% confidence interval from 55.0 to 62.0 and 227 average annual cases over 2017-2021.
• CI*Rank ⋔ : 39 (24, 48)
• Percent of Cases with Late Stage : 58.9

Rhode Island⁶

• Rate : The incidence rate is 57.9 with a 95% confidence interval from 54.6 to 61.4 and 238 average annual cases over 2017-2021.
• CI*Rank ⋔ : 40 (27, 48)
• Percent of Cases with Late Stage : 59.2

Nevada⁶

• Rate : The incidence rate is 57.9 with a 95% confidence interval from 55.8 to 60.1 and 602 average annual cases over 2017-2021.
• CI*Rank ⋔ : 41 (31, 46)
• Percent of Cases with Late Stage : 55.8

Colorado⁶

• Rate : The incidence rate is 56.9 with a 95% confidence interval from 55.3 to 58.5 and 1,026 average annual cases over 2017-2021.
• CI*Rank ⋔ : 42 (35, 47)
• Percent of Cases with Late Stage : 61.4

California³

• Rate : The incidence rate is 56.1 with a 95% confidence interval from 55.5 to 56.7 and 7,141 average annual cases over 2017-2021.
• CI*Rank ⋔ : 43 (40, 47)
• Percent of Cases with Late Stage : 56.0

District of Columbia⁶

• Rate : The incidence rate is 55.7 with a 95% confidence interval from 50.9 to 60.8 and 103 average annual cases over 2017-2021.
• CI*Rank ⋔ : 44 (26, 50)
• Percent of Cases with Late Stage : 52.8

Arizona⁶

• Rate : The incidence rate is 55.5 with a 95% confidence interval from 54.2 to 56.8 and 1,430 average annual cases over 2017-2021.
• CI*Rank ⋔ : 45 (40, 48)
• Percent of Cases with Late Stage : 58.3

Connecticut³

• Rate : The incidence rate is 55.1 with a 95% confidence interval from 53.3 to 56.9 and 750 average annual cases over 2017-2021.
• CI*Rank ⋔ : 46 (39, 48)
• Percent of Cases with Late Stage : 55.5

New Mexico³

• Rate : The incidence rate is 54.4 with a 95% confidence interval from 52.0 to 56.8 and 420 average annual cases over 2017-2021.
• CI*Rank ⋔ : 47 (39, 49)
• Percent of Cases with Late Stage : 56.4

Vermont⁶

• Rate : The incidence rate is 53.4 with a 95% confidence interval from 49.4 to 57.6 and 140 average annual cases over 2017-2021.
• CI*Rank ⋔ : 48 (36, 50)
• Percent of Cases with Late Stage : 56.2

Utah³

• Rate : The incidence rate is 48.4 with a 95% confidence interval from 46.3 to 50.7 and 383 average annual cases over 2017-2021.
• CI*Rank ⋔ : 50 (48, 50)
• Percent of Cases with Late Stage : 58.1

Puerto Rico⁶

• Rate : The incidence rate is 14.6 with a 95% confidence interval from 14.1 to 15.1 and 676 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 48.9

Indiana⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 12/09/2024 3:09 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
³ Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
⁵ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
⁶ Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.